Zhejiang Shengda Pharm (603079) — Cash Flow-to-Debt Ratio
Zhejiang Shengda Pharm (603079) has a Cash Flow-to-Debt Ratio of 0.08x as of September 2025, meaning its operating cash flow of CN¥45.27 Million could theoretically repay 0% of its total liabilities (CN¥542.15 Million) in one year. Check Zhejiang Shengda Pharm total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhejiang Shengda Pharm Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Zhejiang Shengda Pharm across 14 annual periods. Also explore balance sheet size of Zhejiang Shengda Pharm for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Zhejiang Shengda Pharm (2012–2025)
Year-by-year debt coverage analysis for Zhejiang Shengda Pharm. For market capitalisation and broader financial context, see 603079 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.24x | CN¥138.88 Million | CN¥583.75 Million | ▼ -19.3% |
| 2024 | 0.29x | CN¥147.88 Million | CN¥501.34 Million | ▲ +105.7% |
| 2023 | 0.14x | CN¥64.42 Million | CN¥449.20 Million | ▲ +9.8% |
| 2022 | 0.13x | CN¥40.72 Million | CN¥311.76 Million | ▼ -25.0% |
| 2021 | 0.17x | CN¥74.46 Million | CN¥427.84 Million | ▼ -80.4% |
| 2020 | 0.89x | CN¥333.20 Million | CN¥375.80 Million | ▲ +840.2% |
| 2019 | 0.09x | CN¥58.55 Million | CN¥620.88 Million | ▼ -54.9% |
| 2018 | 0.21x | CN¥88.69 Million | CN¥424.29 Million | ▼ -52.4% |
| 2017 | 0.44x | CN¥95.33 Million | CN¥217.27 Million | ▲ +81.1% |
| 2016 | 0.24x | CN¥73.00 Million | CN¥301.35 Million | ▼ -69.7% |
| 2015 | 0.80x | CN¥148.07 Million | CN¥185.05 Million | ▲ +419.6% |
| 2014 | 0.15x | CN¥34.40 Million | CN¥223.40 Million | ▼ -67.2% |
| 2013 | 0.47x | CN¥105.28 Million | CN¥224.00 Million | ▲ +37.2% |
| 2012 | 0.34x | CN¥110.08 Million | CN¥321.43 Million | — |